Does LEUPROLIDE Cause Device occlusion? 786 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 786 reports of Device occlusion have been filed in association with LEUPROLIDE (Fensolvi). This represents 1.1% of all adverse event reports for LEUPROLIDE.
786
Reports of Device occlusion with LEUPROLIDE
1.1%
of all LEUPROLIDE reports
3
Deaths
25
Hospitalizations
How Dangerous Is Device occlusion From LEUPROLIDE?
Of the 786 reports, 3 (0.4%) resulted in death, 25 (3.2%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Device occlusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 786 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Device occlusion?
PEGFILGRASTIM (3,239)
CARBIDOPA\LEVODOPA (1,464)
SOMATROPIN (823)
EPOPROSTENOL (580)
TREPROSTINIL (458)
ALBUTEROL (431)
MEDROXYPROGESTERONE (284)
BACLOFEN (254)
LEVODOPA (224)
RISPERIDONE (182)
Which LEUPROLIDE Alternatives Have Lower Device occlusion Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM